Cellyan Biotechnology Co., Ltd
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| HKPD | YI | S1R.F | GU5.F | 600511.SS | 068760.KQ | |
|---|---|---|---|---|---|---|
| Market cap | 4.56M | 26.39M | 4.64B | 2.36B | 21.87B | 1.79T |
| P/E (TTM) | — | 0.3 | 7.4 | 8.5 | 11.1 | — |
| Forward P/E | — | 21.4 | — | — | 10.3 | — |
| Price/book | 0.2 | -0.2 | 0.4 | 0.5 | 1.1 | — |
| Dividend yield | — | — | 4.67% | 6.66% | 2.77% | 0.53% |
| 1-year change | −92.29% | −30.07% | −3.85% | −30.48% | −2.40% | −39.86% |
| Today | −4.64% | −0.66% | 0.00% | −0.68% | +0.28% | +6.61% |
The closest companies by business and industry (Medical Distribution). Prices may be delayed up to 20 min.
Latest news
All HKPD news ›Basic earnings per share (basic EPS) of Cellyan Biotechnology Co., Ltd – NASDAQ:HKPD
TradingView Cellyan Biotechnology Co., Ltd Basic earnings per share (basic EPS) of Cellyan Biotechnology Co., Ltd
Non-operating income (total) of Cellyan Biotechnology Co., Ltd – NASDAQ:HKPD
TradingView Cellyan Biotechnology Co., Ltd Non-operating income (total) of Cellyan Biotechnology Co., Ltd
Cellyan Biotechnology Announces a 1-for-20 Reverse Stock Split
Nasdaq Cellyan Biotechnology Announces a 1-for-20 Reverse Stock Split Oct 21, 2026 8:00am EDT HONG KONG, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over-the-co
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- nasdaq.com1
- stocktitan.net1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.